Close

UPDATE: Barclays Downgrades Scotts Miracle-Gro (SMG) to Equalweight

April 21, 2022 3:08 AM EDT
Get Alerts SMG Hot Sheet
Price: $42.75 -3.11%

Rating Summary:
    5 Buy, 13 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 10 | Down: 4 | New: 31
Join SI Premium – FREE
(Updated - April 21, 2022 5:29 AM EDT)

Barclays analyst Gaurav Jain downgraded Scotts Miracle-Gro (NYSE: SMG) from Overweight to Equalweight with a price target of $110.00 (from $150.00).

The analyst comments "After a c40% EPS growth p.a in FY20/21, we expect a -19% dip in EPS in FY22E due to weakness in US Consumer business. Post FY22, we expect SMG to organically compound EPS at HSD, driven by Hawthorne growth, a recovery in US Consumer margins and share repurchases."

For an analyst ratings summary and ratings history on Scotts Miracle-Gro click here. For more ratings news on Scotts Miracle-Gro click here.

Shares of Scotts Miracle-Gro closed at $117.51 yesterday.


You May Also Be Interested In





Related Categories

Analyst Comments, Analyst PT Change, Downgrades

Related Entities

Barclays